Logo image of DALN

DALLASNEWS CORP (DALN) Stock Fundamental Analysis

NASDAQ:DALN - Nasdaq - US2350501019 - Common Stock

6.57  -0.09 (-1.35%)

Fundamental Rating

1

DALN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 92 industry peers in the Media industry. DALN has a bad profitability rating. Also its financial health evaluation is rather negative. DALN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DALN had negative earnings in the past year.
DALN had a negative operating cash flow in the past year.
DALN had negative earnings in 4 of the past 5 years.
DALN had negative operating cash flow in 4 of the past 5 years.
DALN Yearly Net Income VS EBIT VS OCF VS FCFDALN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.82%, DALN is doing worse than 78.16% of the companies in the same industry.
Industry RankSector Rank
ROA -9.82%
ROE N/A
ROIC N/A
ROA(3y)-8.49%
ROA(5y)-4.89%
ROE(3y)-106.88%
ROE(5y)-63.88%
ROIC(3y)N/A
ROIC(5y)N/A
DALN Yearly ROA, ROE, ROICDALN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

The Gross Margin of DALN (95.50%) is better than 98.85% of its industry peers.
In the last couple of years the Gross Margin of DALN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DALN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y1.01%
DALN Yearly Profit, Operating, Gross MarginsDALN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

DALN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DALN has been reduced compared to 1 year ago.
The number of shares outstanding for DALN has been reduced compared to 5 years ago.
There is no outstanding debt for DALN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DALN Yearly Shares OutstandingDALN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DALN Yearly Total Debt VS Total AssetsDALN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

DALN has an Altman-Z score of -7.98. This is a bad value and indicates that DALN is not financially healthy and even has some risk of bankruptcy.
DALN has a Altman-Z score of -7.98. This is amonst the worse of the industry: DALN underperforms 93.10% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.98
ROIC/WACCN/A
WACC9.25%
DALN Yearly LT Debt VS Equity VS FCFDALN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

DALN has a Current Ratio of 1.09. This is a normal value and indicates that DALN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DALN (1.09) is worse than 70.11% of its industry peers.
DALN has a Quick Ratio of 1.04. This is a normal value and indicates that DALN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.04, DALN is doing worse than 70.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.04
DALN Yearly Current Assets VS Current LiabilitesDALN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

DALN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.76%, which is quite good.
The Revenue for DALN has decreased by -11.40% in the past year. This is quite bad
The Revenue has been decreasing by -7.14% on average over the past years.
EPS 1Y (TTM)13.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182.18%
Revenue 1Y (TTM)-11.4%
Revenue growth 3Y-3.26%
Revenue growth 5Y-7.14%
Sales Q2Q%-9.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DALN Yearly Revenue VS EstimatesDALN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
DALN Yearly EPS VS EstimatesDALN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DALN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DALN Price Earnings VS Forward Price EarningsDALN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DALN Per share dataDALN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.10%, DALN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.46, DALN pays a better dividend. On top of this DALN pays more dividend than 97.70% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, DALN pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.1%

5.2 History

The dividend of DALN decreases each year by -8.16%.
DALN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-8.16%
Div Incr Years0
Div Non Decr Years0
DALN Yearly Dividends per shareDALN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

The earnings of DALN are negative and hence is the payout ratio. DALN will probably not be able to sustain this dividend level.
DP-28.31%
EPS Next 2YN/A
EPS Next 3YN/A
DALN Yearly Income VS Free CF VS DividendDALN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

DALLASNEWS CORP

NASDAQ:DALN (1/22/2025, 10:29:23 AM)

6.57

-0.09 (-1.35%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)03-04 2025-03-04
Inst Owners42.24%
Inst Owner Change0%
Ins Owners5.77%
Ins Owner Change4.69%
Market Cap35.15M
Analysts82.86
Price TargetN/A
Short Float %4.4%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield 9.1%
Yearly Dividend0.64
Dividend Growth(5Y)-8.16%
DP-28.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS23.98
BVpS-0.11
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.5%
FCFM N/A
ROA(3y)-8.49%
ROA(5y)-4.89%
ROE(3y)-106.88%
ROE(5y)-63.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y1.01%
F-Score4
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 350.19%
Cap/Sales 4.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.04
Altman-Z -7.98
F-Score4
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)38.47%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.4%
Revenue growth 3Y-3.26%
Revenue growth 5Y-7.14%
Sales Q2Q%-9.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.18%
OCF growth 3YN/A
OCF growth 5YN/A